REFERENCES
1. Zhang X, Wang H, Zhang Y, Lu X, Chen L, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159:134-47.
2. Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160:1125-34.
3. Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141-57.
4. Tan WL, Lim BT, Anene-nzelu CG, et al. A landscape of circular RNA expression in the human heart. Cardiovasc Res. 2017:cvw250.
5. Mcdonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599-726.
6. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022:145.
7. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118:3272-87.
8. Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012-2015. Eur J Heart Fail. 2019;21:1329-37.
9. An D, Zeng Q, Zhang P, et al. Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice. Redox Biol. 2021;46:102088.
10. Tran DH, May HI, Li Q, et al. Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling. Nat Commun. 2020;11:1771.
11. Zhai C, Qian G, Wu H, et al. Knockdown of circ_0060745 alleviates acute myocardial infarction by suppressing NF‐κB activation. J Cell Mol Med. 2020;24:12401-10.
12. Gao X, Liu C, Zhang Y, et al. The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death Differ. 2021;29:527-39.
13. Madè A, Bibi A, Garcia-manteiga JM, et al. circRNA-miRNA-mRNA deregulated network in ischemic heart failure patients. Cells. 2023;12:2578.
14. Neufeldt D, Schmidt A, Mohr E, et al. Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival. Basic Res Cardiol. 2024;119:613-32.
15. Acharya P, Parkins S, Tranter M. RNA binding proteins as mediators of pathological cardiac remodeling. Front Cell Dev Biol. 2024;12:1368097.
16. Garikipati VNS, Verma SK, Cheng Z, et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun. 2019;10:4317.
17. Bian Y, Pang P, Li X, et al. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart. J Mol Cell Cardiol. 2021;158:128-39.
18. Wang J, Gareri C, Rockman HA. G-protein-coupled receptors in heart disease. Circ Res. 2018;123:716-35.
19. Shen Z, Shao YL, Liu W, Zhang Q, Yuan L. Prediction of back-splicing sites for circRNA formation based on convolutional neural networks. BMC Genom. 2022;23:581.
20. Greene J, Baird A, Brady L, et al. cirRNA: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38.
21. Kirio K, Patop IL, Anduaga AM, et al. cirRNA exhibit exceptional stability in the aging brain and serve as reliable age and experience indicators. Cell Rep. 2025;44:115485.
22. Hwang HJ, Kim YK. Molecular mechanisms of circular RNA translation. Exp Mol Med. 2024;56:1272-80.
24. Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of cirRNA. Nat Rev Genet. 2019;20:675-91.
25. Zhang L, Zhang Y, Yu F, Li X, Gao H, Li P. The circRNA-miRNA/RBP regulatory network in myocardial infarction. Front Pharmacol. 2022;13:941123.
26. Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25:981-4.
27. Huang C, Liang D, Tatomer DC, Wilusz JE. A length-dependent evolutionarily conserved pathway controls nuclear export of cirRNA. Genes Dev. 2018;32:639-44.
28. Mahmoudi E, Cairns MJ. cirRNA are temporospatially regulated throughout development and ageing in the rat. Sci Rep. 2019;9:2564.
29. Bibi A, Bartekova M, Gandhi S, et al. Circular RNA regulatory role in pathological cardiac remodelling. Br J Pharmacol. 2024;182:316-39.
30. Cheng Y, Su Y, Wang S, et al. Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia. Genes. 2020;11:868.
31. Ma C, Gu R, Wang X, et al. circRNA CDR1as promotes pulmonary artery smooth muscle cell calcification by upregulating CAMK2D and CNN3 via sponging miR-7-5p. Mol Ther Nucl Acids. 2020;22:530-41.
32. Zhang N, Wang X, Li Y, et al. Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer. Commun Biol. 2025;8:77.
33. Zang Y, Li J, Wan B, Tai Y. circRNA circ‐CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR‐646. J Cell Mol Med. 2020;24:2423-33.
34. Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22-37.e9.
35. Zhou C, Molinie B, Daneshvar K, et al. Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep. 2017;20:2262-76.
36. Payea MJ, Dar SA, Malla S, Maragkakis M. Ribonucleic acid-mediated control of protein translation under stress. Antioxid Redox Signal. 2023;39:374-89.
37. Zhang J, Zhou R, Zhang H, et al. Decoding circRNA translation: challenges and advances in computational method development. Front Genet. 2025;16:1654305.
38. Shan T, Yang T, Jing P, et al. Circular RNA IGF1R promotes cardiac repair via activating β-catenin signaling by interacting with DDX5 in mice after ischemic insults. Research. 2024;7:0451.
40. Deng Y, Wang J, Xie G, Zeng X, Li H. Circ-HIPK3 strengthens the effects of adrenaline in heart failure by MiR-17-3p - ADCY6 axis. Int J Biol Sci. 2019;15:2484-96.
41. Zhang L, Wang Y, Yu F, Li X, Gao H, Li P. CircHIPK3 plays vital roles in cardiovascular disease. Front Cardiovasc Med. 2021;8:733248.
42. Xu X, Wang J, Wang X. Silencing of circHIPK3 inhibits pressure overload-induced cardiac hypertrophy and dysfunction by sponging miR-185-3p. Drug Des Devel Ther. 2020;14:5699-710.
43. Wang W, Wang L, Yang M, et al. Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy. Cell Death Dis. 2021;12:1069.
45. Lim TB, Aliwarga E, Luu TDA, et al. Targeting the highly abundant circular RNA circSLC8A1 in cardiomyocytes attenuates pressure overload induced hypertrophy. Cardiovasc Res. 2019;115:1998-2007.
46. Yang T, Long T, Du T, Chen Y, Dong Y, Huang Z. Circle the cardiac remodeling with circRNAs. Front Cardiovasc Med. 2021;8:702586.
47. Li M, Ding W, Tariq MA, et al. A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p. Theranostics. 2018;8:5855-69.
48. Li H, Xu J, Fang X, et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc Res. 2020;116:1323-34.
49. Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J. 2016;37:2602-11.
50. Yuan Z, Huang S, Jin X, Li S. cirRNA in cardiovascular diseases: molecular mechanisms, therapeutic advances, and innovations. Genes. 2024;15:1423.
51. Capirossi G, Brasini S, Tremoli E, Binatti A, Roncarati R. cirRNA in cardiovascular physiopathology: from molecular mechanisms to therapeutic opportunities. Int J Mol Sci. 2025;26:9725.
52. Zhang J, Zhao F. Circular RNA discovery with emerging sequencing and deep learning technologies. Nat Genet. 2025;57:1089-102.
53. Nielsen AF, Bindereif A, Bozzoni I, et al. Best practice standards for circular RNA research. Nat Methods. 2022;19:1208-20.
54. Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17:679-92.
55. Siede D, Rapti K, Gorska A, et al. Identification of cirRNA with host gene-independent expression in human model systems for cardiac differentiation and disease. J Mol Cell Cardiol. 2017;109:48-56.
56. Hatzimanolis O, Sykes AM, Cristino AS. cirRNA in neurological conditions - computational identification, functional validation, and potential clinical applications. Mol Psychiatry. 2025;30:1652-75.
57. Wen N, Peng D, Xiong X, et al. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring. Sig Transduct Target Ther. 2024;9:107.
58. Dong J, Zeng Z, Huang Y, Chen C, Cheng Z, Zhu Q. Challenges and opportunities for circRNA identification and delivery. Crit Rev Biochem Mol Biol. 2023;58:19-35.
59. Young T, Chang Wang K, James Varley A, Li B. Clinical delivery of circular RNA: lessons learned from RNA drug development. Adv Drug Delivery Rev. 2023;197:114826.
60. Cao X, Cai Z, Zhang J, Zhao F. Engineering circular RNA medicines. Nat Rev Bioeng. 2024;3:270-87.
61. You Q, Yu J, Pan R, Feng J, Guo H, Liu B. Decoding the regulatory roles of circular RNAs in cardiac fibrosis. Non-coding RNA Res. 2025;11:115-30.
62. Bo X, Li Q, Chen S, et al. Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study. J Cardiothorac Surg. 2025;20:66.
